- Short Report
- Open Access
Characterization of endemic Shigella boydii strains isolated in Iran by serotyping, antimicrobial resistance, plasmid profile, ribotyping and pulsed-field gel electrophoresis
BMC Research Notes volume 1, Article number: 74 (2008)
Shigellosis is one of the major causes of morbidity in children with diarrhea in Iran. The present study was undertaken to characterize apparently sporadic Shigella boydii strains isolated from pediatric patients in Iran.
Ten S. boydii strains isolated from pediatric cases of gastroenteritis and acute diarrhea in Tehran between December 2002 and November 2003 were submitted to serotyping, antimicrobial susceptibility testing, plasmid profile analysis, ribotyping and pulsed field gel electrophoresis (PFGE). Seven isolates were attributed to serotype 2, whereas the remaining three belonged to serotypes 14, 18, 19, respectively. Six drug resistance phenotypes (R1 to R6) were defined with R4 – streptomycin (STR), ampicillin (AMP), sulfamethoxazole-trimethoprim (SXT) – being the most prevalent. Plasmid analysis resulted in seven different plasmid profiles with one to five DNA bands. All strains, but one, shared the same ribotype, but PFGE differentiated them in four groups.
Based upon ribotyping and PFGE results, endemic circulation of S. boydii in Tehran, Iran, could be attributed to a few clones. Resistance pattern and plasmid profile analysis proved to be very effective in discriminating apparently unrelated strains of S. boydii.
Shigellosis is one of the major causes of morbidity and mortality in children with diarrhea in developing countries. Worldwide, the disease causes around 1,100,000 deaths per year, and two-thirds of the patients are children under 5 years of age. Shigellosis is caused by four serogroups of Shigella including serogroup A (S. dysenteriae), serogroup B (S. flexneri), serogroup C (S. boydii), and serogroup D (S. sonnei). Among Shigella serogroups, S. flexneri and S. sonnei are most prevalent in the developing and industrialized countries, respectively. S. dysenteriae is detected mostly in South Asia and sub-Saharian Africa . S. boydii has been less frequently reported worldwide compared to other Shigella serogroups [2, 3]. It is relatively rare in developed countries and is typically associated with individuals who have travelled to endemic areas. Isolation rate of this species is less than 1–2% of the total Shigella isolates, except in the Indian subcontinent .
Shigellosis is one of the major causes of morbidity in children with diarrhea in Iran [5–9], but reports about prevalence of Shigella serogroups and their phenotypic and genetic epidemiological features are limited. Furthermore, specific studies to investigate the relatedness between the S. boydii strains isolated from clinical cases in Iran have never been undertaken.
Several typing methods such as serotyping, drug resistance pattern, plasmid analysis, ribotyping, and pulsed field gel electrophoresis (PFGE) have been frequently used for subtyping of Shigella in epidemiological investigations [3, 10–14].
The present study was undertaken to characterize S. boydii strains isolated from pediatric cases of gastroenteritis and acute diarrhea in Tehran, Iran, between December 2002 and November 2003 by serotyping, antimicrobial susceptibility testing, plasmid profile analysis, ribotyping and PFGE. To the best of our knowledge this is the first study of its kind to be carried out in Iran.
Fecal specimens and rectal swabs were inoculated into Cary-Blair transport medium and processed within 2–4 h. Specimens were cultured on Shigella-Salmonella (SS), Hektoen-Enteric (HE), Xylose Lysine Deoxycholate (XLD) and MacConkey (MC) agars (Difco, Detroit, MI, USA) and incubated at 37°C for 24 h. Suspected colonies were picked from the culture plates and subjected to further analysis by biochemical tests for the identification of possible Shigella colonies. Shigella spp. were preliminarily identified by Gram stain, colony morphology, lactose fermentation, motility, as well as by API20E .
For serotyping, strains of Shigella were subcultured on trypticase soy agar (Difco, Detroit, MI, USA) and tested for agglutination on glass slides. Strains were serogrouped by using commercially-available polyclonal antisera from MAST Group LTD (Mast House, Derby Road, Bootle, Merseyside, L201EA). The serotypes of S. boydii were determined with commercially available monovalent antisera (Staten Serum Institut, Copenhagen, Denmark).
Antimicrobial susceptibility testing
Antimicrobial susceptibility test was performed by the disk diffusion method according to the guidelines of the Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory Standards [NCCLS], 2000) . The following antimicrobial agents were tested; ampicillin, AMP (10 μg); amoxicillin-clavulanic acid, AMX (30 μg); cephalothin, CF (30 μg); cefixime, CFM (5 μg); ceftazidime, CAZ (30 μg); ceftizoxime, CT (30 μg); ceftriaxone, CRO (30 μg); amikacin, AN (30 μg); gentamicin, GM (10 μg); kanamycin, K (30 μg); streptomycin, STR (10 μg); chloramphenicol, C (30 μg); sulfamethoxazole-trimethoprim, SXT (23.75/1.25/μg); tetracycline, TET (30 μg); ciprofloxacin, CP (5 μg); nalidixic acid, NA (30 μg). Escherichia coli ATCC 25922 was used as a quality control strain.
The High Pure plasmid isolation kit (Roche, Mannheim, Germany) was used to isolate the bacterial plasmids in accordance with the manufacturer's recommendations. This extraction procedure is suitable for detection of small plasmids (less than 20 kbp molecular size) only. However, since large virulence plasmids carried by all four Shigella serogroups are associated to virulence properties and do not contribute to the discriminative power [11, 17, 18], the method was considered to be reliable for subtyping purposes.
Plasmid DNA was then separated on a 0.8% agarose gel in Tris-borate-EDTA (TBE) buffer, pH 8.2, by horizontal electrophoresis. The strains were grouped depending on their banding pattern. Lambda DNA cleaved by Eco R1 and Hin dIII (Promega, Madison, WI, US) was used as electrophoresis marker.
Ribotyping was performed according to previous reports . Bacterial DNA was digested with Pvu II restriction enzyme under conditions recommended by the manufacturer (Roche Diagnostics, Mannheim, Germany). Digested DNA fragments were resolved on a 0.8% agarose gel in TBE buffer and then transferred onto nylon membrane by the alkali-blotting procedure on a vacuum blotter. Hybridization was then performed with a digoxigenin-11-dUTP (DIG) labeled oligonucleotide probe mixture . The membranes were then visualized by addition of alkaline phosphate-conjugated anti-digoxigenin antibody (Roche Diagnostic GmbH, Mannheim, Germany) and nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as the substrate.
The S. boydii isolates were analyzed by PFGE after DNA digestion with the restriction endonuclease Xba I (Promega, Madison, WI, USA) using the PulseNet protocol . DNA of Salmonella serotype Braenderup strain H9812 was digested with Xba I and used as molecular weight standard. Strain H9812 was kindly provided by the National Reference Centre for Enteric Pathogens at the Istituto Superiore di Sanità, Rome, Italy. The electrophoretic profiles were visually compared and interpreted according to the criteria of Tenover et al. .
During the one-year period from December 2002 and November 2003, a total of 302 Shigella strains had been isolated from enteritis cases in children at the Children Medial Center and Mofid Children Hospital and three additional large hospitals including Baqiyatallah, Millad and Firozabadi in Tehran.
Ten isolates of S. boydii were available for the study. No epidemiological relationship had been identified within the strains by conventional investigation.
Seven strains belonged to serotype 2, whereas serotypes 14, 18, and 19 were each represented by one strain.
All isolates were resistant to sulfamethoxazole-trimethoprim and all, but one, to streptomycin. Additional resistances to nalidixic acid or ampicillin were exhibited by four isolates. The majority of the isolates were susceptible to amoxicillin-clavulanic acid, chloramphenicol and tetracycline. All isolates were fully susceptible to kanamycin, gentamicin, cephalothin, ceftriaxone, ceftizoxime, ceftazidime, cefotaxime and ciprofloxacin. Table 1 summarizes the antimicrobial resistance patterns.
Plasmid analysis of S. boydii resulted in seven different plasmid profiles (P1 to P7) with one to five DNA bands with a molecular weight lower than approximately 20 kb (Fig. 1). The most prevalent plasmid profile was P6 (40%). Other plasmid profiles were unique (Table 1).
Drug resistance patterns combined with plasmid profiles stratified the ten S. boydii isolates into nine groups.
Ribotyping produced 14 fragments when DNA from all S. boydii isolates was digested with Pvu II. Two ribotype patterns were observed, of which ribotype I include nine isolates and ribotype II one only isolate (Fig. 2).
Four pulsotypes, named A to D, were identified by Xba I-PFGE among the isolates under study (Fig. 3). Type A included seven isolates, whereas types B, C and D one isolate each, respectively.
The results of the different subtyping methods are illustrated by the Table 1. Combining results of the phenotypic and genetic subtyping methods, nine different complete patterns were identified.
Of 302 Shigella isolates recovered from Iranian pediatric cases in the period December 2002 to November 2003, 10 (3.3%) strains were identified as S. boydii and analyzed in this study by different phenotypic and molecular subtyping methods. The prevalence rate of S. boydii is comparable with a recent study in Iran in which 3.1% of Shigella strains belonged to this serogroup .
Antimicrobial drug resistance pattern analysis has been widely applied in epidemiologic studies of Shigella through the years . Using this method, six resistant phenotypes were recognized with resistance to streptomycin, ampicillin and sulfamethoxazole-trimethoprim being the most frequent pattern. Our results suggest that this method may represent an undemanding, but highly discriminative approach for differentiation of S. boydii. Moreover, it is the least expensive and most widely available subtyping tool and could be considered as a preliminary screening approach in assessing strain relatedness. Nevertheless, significance of drug resistance profiles in long-term epidemiologic studies is limited by two concurrent factors: the strong selective pressure caused by antibacterial drug abuse/misuse in hospital and, increasingly, in community settings and the phenotype instability [24, 25]. Indeed, all S. boydii strains were resistant to trimethoprim-sulfamethoxazole and all, but one, to streptomycin, antibacterial drugs that are both commonly used in Iran as an empiric therapy in the treatment of shigellosis and the other bacterial enteric diseases. Furthermore, the changes in resistance phenotypes that have been observed in Shigella have recently been supposedly attributed to the transposition activity of insertion sequences distributed at high frequency through the genome with a consequent disruption of antimicrobial resistance sequences .
Plasmid profile analysis has been extensively used on Shigella strains. This method is cheap and quick, requiring one hour approximately of hands-on time, and 24 hours to be completed. Shigella species may harbor plasmids ranging from 2 to as many as 10 different populations [26, 27]. Some previous studies used plasmid profiles to characterize isolates of S. boydii [3, 18, 9]. The sizes of the plasmids among all S. boydii isolates ranged from 1 to 21.2 kb that is comparable with the results previously reported from USA  and Iran . In our study, plasmid profile analysis was able to differentiate seven patterns among 10 isolates: P6 only was shared by four strains, while the remaining plasmid profiles were unique. Litwin et al.  also found six plasmid patterns among 12 strains of S. boydii isolated from Pima County, Arizona between April 1986 and May 1987. Those patterns contained one to five plasmids which ranged in size from 1.4 to >20 kb. In other studies, however, plasmid profile analysis showed an identical plasmid pattern in 23 of 25 strains studied . In a recent study carried out in Shiraz, Iran, Farshad and her colleagues identified three genotypes among three clinical isolates of S. boydii on the basis of their plasmid profiles .
Ribotyping was applied based upon previous findings proving that rDNA restriction pattern analysis may be a valuable tool in epidemiological research on S. boydii [3, 10]. In our study, however, all S. boydii strains were categorized into two patterns only. Moreover, all but one isolates, belonged to ribotype I. Hence, in our setting ribotyping did not prove to be useful, despite the encouraging results obtained on Shigella during previous investigations [12, 28]. However, our finding is similar to recent reports from other developing countries, such as Bangladesh .
PFGE also, that has consistently proved to be a highly discriminative subtyping method in epidemiological investigation of many bacterial pathogens , divided our strains into four groups closely associated to serotype. The association of the serotype 2/PFGE A pattern subtype with different plasmid profiles could suggest the circulation during the period under study of a major endemic S. boydii clone, including strains that were going through some differentiation steps probably by acquisition or loss of extra-chromosomal DNA.
Though our results have inherent limits due to the lowest incidence of S. boydii infections in Iran and the consequent small number of available strains, subtyping relying upon more temporally and spatially stable molecular markers, such as PFGE and ribotyping, suggests that endemic circulation of this enteric pathogen should be attributed to a few bacterial clones. Simultaneously, less stable markers, such as drug resistance pattern and plasmid profile analysis, were very effective in finely discriminating apparently unrelated strains of S. boydii.
Low endemic circulation of S. boydii in Tehran, Iran, may be attributed to a few clones diverging towards heterogeneous drug resistance phenotypes and plasmid profiles.
The different methods could provide more or less sensitive interpreting keys suitable for long term – ribotyping, PFGE – or short term – drug resistance and plasmid pattern – epidemiological studies.
To our best knowledge, this is the first report on the characterization by different methods of S. boydii strains isolated in Iran. The results obtained from present study could be helpful for a future epidemiological surveillance of Shigella in this country.
Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM: Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull WHO. 1999, 77: 651-666.
Rowe B, Gross RJ, Allen HA: Shigella dysenteriae and Shigella boydii in England and Wales during 1972 and 1973. Br Med J. 1974, 3: 641-642.
Bratoeva MP, John JF, Barg NL: Molecular epidemiology of trimethoprim-resistant Shigella boydii serotype 2 strains from Bulgaria. J Clin Microbiol. 1992, 30: 1428-1431.
Woodward DL, Clark CG, Caldeira RA, Ahmed R, Soule G, Bryden L, Tabor H, Melito P, Foster R, Walsh J, Ng LK, Malcolm GB, Strockbine N, Rodgers FG, Canadian Public Health Laboratory Network: Identification and characterization of Shigella boydii 20 serovar nov., a new and emerging Shigella serotype. J Med Microbiol. 2005, 54: 741-748. 10.1099/jmm.0.46095-0.
MoezArdalan K, Zali MR, Soltan-Dallal MM, Hemami MR, Salmanzadeh-Ahrabi S: Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Karaj, Tehran, Iran. J Health Popul Nutr. 2003, 21: 96-102.
Nikkah J, Mehr-Movahead A: Antibiotic resistance among Shigella species isolated in Tehran, Iran. Ann Trop Med Parasitol. 1988, 82: 481-483.
Ranjbar R, Aleo A, Giammanco GM, Dionisi AM, Sadeghifard N, Mammina C: Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002–2003. BMC Infect Dis. 2007, 22: 62-10.1186/1471-2334-7-62.
Ranjbar R, Soltan Dallal MM, Pourshafie MR, Aslani MM, Majdzadeh R, Khorramizadeh MR: Serogroup distribution of Shigella spp. in Tehran. Iranian J Publ Health. 2004, 33: 32-35.
Farshad S, Sheikhi R, Japoni A, Basiri E, Alborzi A: Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes. J Clin Microbiol. 2006, 44: 2879-2883. 10.1128/JCM.00310-06.
Nastasi A, Villafrate MR, Mammina C, Pontello M, Ricci M: Molecular analysis of strains of Shigella boydii isolated in northern and southern Italy. Res Microbiol. 1990, 141: 1163-1172. 10.1016/0923-2508(90)90089-9.
Litwin CM, Leonard RB, Carroll KC, Drummond WK, Pavia AT: Characterization of endemic strains of Shigella sonnei by use of plasmid DNA analysis and pulsed-field gel electrophoresis to detect patterns of transmission. J Infect Dis. 1997, 175: 864-870. 10.1086/513983.
Mendoza MC, Martin MC, Gonzalez-Hevia MA: Usefulness of ribotyping in a molecular epidemiology study of shigellosis. Epidemiol Infect. 1996, 116: 127-135.
Nastasi A, Pignato S, Mammina C, Giammanco G: rRNA gene restriction patterns and biotypes of Shigella sonnei. Epidemiol Infect. 1993, 110: 23-30.
Liu PY, Lau YJ, Hu BS, Shyr JM, Shi ZY, Tsai WS, Lin YH, Tseng CY: Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods. J Clin Microbiol. 1995, 33: 1779-1783.
Ewing WH: Edwards and Ewing's identification of Enterobacteriaceae. 1986, Elsevier Science Publishing Co. New York, 169-81.
Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. Approved Standard. Wayne (PA): NCCLS document M2-A7, 7
Litwin CM, Ryan KJ, Chipowsky S, Storm A, McCombie S: Molecular epidemiology of Shigella sonnei in Pima County, Arizona: evidence for a Mexico-related plasmid. J Infect Dis. 1990, 161: 797-800.
Litwin CM, Storm AL, Chipowsky S, Ryan KJ: Molecular epidemiology of Shigella infections: plasmid profiles, serotype correlation, and restriction endonuclease analysis. J Clin Microbiol. 1991, 29: 104-108.
Pourshafie M, Grimont F, Saifi M, Grimont PA: Molecular epidemiological study of Vibrio cholerae isolates from infected patients in Teheran, Iran. J Med Microbiol. 2000, 49: 1085-1090.
Regnault B, Grimont F, Grimont PAD: Universal ribotyping method using a chemically labelled oligonucleotide probe mixture. Res Microbiol. 1997, 148: 649-659. 10.1016/S0923-2508(99)80064-3.
Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ: Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006, 3: 59-67. 10.1089/fpd.2006.3.59.
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995, 33: 2233-9.
Hoe CH, Yasin RM, Koh YT, Thong KL: Antimicrobial susceptibility and pulsed-field gel electrophoresis of Shigella sonnei strains in Malaysia (1997–2000). J Appl Microbiol. 2005, 99: 133-140. 10.1111/j.1365-2672.2005.02581.x.
Maslow JN, Mulligan ME, Arbeit RD: Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis. 1993, 17: 153-164.
Wei HL, Wang YW, Li CC, Tung SK, Chiou CS: Epidemiology and evolution of genotype and antimicrobial resistance of an imported Shigella sonnei clone circulating in central Taiwan. Diagn Microbiol Infect Dis. 2007, 58: 469-75. 10.1016/j.diagmicrobio.2007.03.006.
Jamieson AF, Bremner DA, Bergquist PL, D Lane HE: Characterization of plasmids from antibiotic-resistant Shigella isolates by agarose gel electrophoresis. J Gen Microbiol. 1979, 113: 73-81.
Surdeanu M, Pencu E, Tonciu M, Mihai I, Ciudin L: Differentiation of Shigella strains by plasmid profile analysis, serotyping and phagetyping. Roum Arch Microbiol Immunol. 2000, 59 (1 - 2): 103-117.
Hinojosa-Ahumada M, Swaminathan B, Hunter SB, Cameron DN, Kiehlbauch JA, Wachsmuth IK, Strockbine NA: Restriction fragment length polymorphisms in rRNA operons for subtyping Shigella sonnei. J Clin Microbiol. 1991, 29: 2380-2384.
Talukder KA, Islam Z, Dutta DK, Islam MA, Khajanchi BK, Azmi IJ, Iqbal MS, Hossain MA, Faruque AS, Nair GB, Sack DA: Antibiotic resistance and genetic diversity of Shigella sonnei isolated from patients with diarrhoea between 1999 and 2003 in Bangladesh. J Med Microbiol. 2006, 55: 1257-63. 10.1099/jmm.0.46641-0.
Lee TM, Chang LL, Chang CY, Wang JC, Pan TM, Wang TK, Chang SF: Molecular analysis of Shigella sonnei isolated from three well-documented outbreaks in school children. J Med Microbiol. 2000, 49: 355-360.
The authors would like to thank for their cooperation Mrs. Mina Abedini from Microbiology laboratory of the Children's Medial Center and Dr. Aurora Aleo from the Centre for Enteric Pathogens of southern Italy, Department of Sciences for Health Promotion "G. D'Alessandro", University, Palermo, Italy.
The authors declare that they have no competing interests.
RR conceived the study, carried out bacterial isolation, drug resistance analysis, plasmid profiling, ribotyping and drafted the manuscript. CM participated in study design and coordination, carried out serotyping, helped to PFGE analysis and draft of the manuscript. MRP and MMSD helped to study design and draft of the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Ranjbar, R., Mammina, C., Pourshafie, M.R. et al. Characterization of endemic Shigella boydii strains isolated in Iran by serotyping, antimicrobial resistance, plasmid profile, ribotyping and pulsed-field gel electrophoresis. BMC Res Notes 1, 74 (2008) doi:10.1186/1756-0500-1-74
- Acute Diarrhea
- Plasmid Profile
- Drug Resistance Phenotype